Literature DB >> 22762046

A technique for periorbital syringomas: intralesional radiofrequency ablation.

Li-Ping Huang1, Leng Zhang, Xing-Lin Wang, Xiao-Cui Liu, Tian-Yu Jiang, Bi-Weng Lin.   

Abstract

AIM: To evaluate the efficacy of intralesional radiofrequency ablation in the treatment of periorbital syringomas.
METHODS: We tried the intralesional radiofrequency ablation for 64 patients with periorbital syringomas from 2007 to 2011. The operation was performed under 2.5 loupe magnifications. The handpiece was assembled with a needle electrode and connected to the radiofrequency ablation apparatus. The electrode was then inserted into the target lesions in dermis and delivering injury to the base of these tumors. Results were assessed clinically by comparing pre- and post-treatment photographs and patient satisfaction rates.
RESULTS: Clinical improvement increased with each subsequent treatment session. The percent of patients whose clinic improvement grade were≥3 after each session was respectively 71.9%(Session1), 83.3%(Session2), and 100%(Session3). The statistical results indicated the concordance of the clinical assessment and the satisfaction level of patients (kappa=0.78 of the session1; kappa=0.82 of the session2). The majority of patients had good or excellent cosmetic results. Postoperatively, there were no permanent side effects or recurrences.
CONCLUSION: As a new technique of minimally invasion, the intralesional radiofrequency ablation was found to be an effective, inexpensive, highly precise and safe way of treating periorbital syringomas.

Entities:  

Keywords:  periorbital syringomas; radiofrequency ablation; treatment

Year:  2012        PMID: 22762046      PMCID: PMC3359034          DOI: 10.3980/j.issn.2222-3959.2012.02.13

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  27 in total

1.  Eruptive pruritic syringomas: treatment with topical atropine.

Authors:  T S Sánchez; E Daudén; A P Casas; A García-Díez
Journal:  J Am Acad Dermatol       Date:  2001-01       Impact factor: 11.527

2.  Syringomas: new approach to an old technique.

Authors:  P Karam; A V Benedetto
Journal:  Int J Dermatol       Date:  1996-03       Impact factor: 2.736

3.  A new treatment for syringoma. Combination of carbon dioxide laser and trichloroacetic acid.

Authors:  W H Kang; N S Kim; Y B Kim; W C Shim
Journal:  Dermatol Surg       Date:  1998-12       Impact factor: 3.398

4.  Electrocautery for treating periorbital syringomas.

Authors:  J A Langtry; A Carruthers
Journal:  Dermatol Surg       Date:  1998-06       Impact factor: 3.398

5.  Temporary tattooing followed by Q-switched alexandrite laser for treatment of syringomas.

Authors:  H J Park; S H Lim; H A Kang; D G Byun; D Houh
Journal:  Dermatol Surg       Date:  2001-01       Impact factor: 3.398

6.  Vulvar syringoma causing pruritus and carcinophobia: treatment by argon laser.

Authors:  D Kopera; H P Soyer; L Cerroni
Journal:  J Cutan Laser Ther       Date:  1999-09

7.  Periorbital syringoma: a pilot study of the efficacy of low-voltage electrocoagulation.

Authors:  Ibrahim K Al Aradi
Journal:  Dermatol Surg       Date:  2006-10       Impact factor: 3.398

8.  The treatment of syringomas by CO(2) laser using a multiple-drilling method.

Authors:  Hyang Joon Park; Dong-Youn Lee; Joo-Heung Lee; Jun-Mo Yang; Eil Soo Lee; Won-Serk Kim
Journal:  Dermatol Surg       Date:  2007-03       Impact factor: 3.398

9.  Syringomas Treated by Intralesional Insulated Needles without Epidermal Damage.

Authors:  Soon-Kwon Hong; Hyun-Jae Lee; Si-Hyung Cho; Jong-Keun Seo; Deborah Lee; Ho-Suk Sung
Journal:  Ann Dermatol       Date:  2010-08-05       Impact factor: 1.444

10.  Radiofrequency ablation of renal tumors: our experience.

Authors:  Jeong Ho Kim; Tae Hyo Kim; Soo Dong Kim; Ki Soo Lee; Gyung Tak Sung
Journal:  Korean J Urol       Date:  2011-08-22
View more
  1 in total

1.  Angiolymphoid hyperplasia of external ear treated with intralesional radiofrequency ablation.

Authors:  Deepika Yadav; Sanjay Singh; Neetu Bhari; Somesh Gupta
Journal:  BMJ Case Rep       Date:  2018-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.